Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-5.34M.
ENTERPRISE VALUE (EV)
$-5.34M
Aclarion, Inc.
Market Cap
$6.67M
Enterprise Value (EV)
$-5.34M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Aclarion, Inc. (ACON) | $6.67M | $-5.34M |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | $15.51M |
| Exicure, Inc. (XCUR)vs › | $6.82M | $5.10M |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.60M | $6.12M |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.57M | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.54M | $7.11M |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | $5.15M |
| KALA BIO, Inc. (KALA)vs › | $7.06M | $6.83M |
| Mangoceuticals, Inc. (MGRX)vs › | $7.07M | $7.16M |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.08M | $7.08M |
Market Cap
$6.67M
Total Debt
$0.00
Cash
$12.02M
Enterprise Value
$-5.34M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
